Fed­er­al judge dis­miss­es kick­back claims in No­var­tis whistle­blow­er case — again

When a fed­er­al judge dis­missed a whistle­blow­er case against No­var­tis back in 2020, the court gave plain­tiffs one last chance to prove the phar­ma gi­ant bribed physi­cians to pre­scribe its mul­ti­ple scle­ro­sis drug Gilenya. On Tues­day, those ef­forts came up short.

US Dis­trict Judge Kim­ba Wood of South­ern New York ruled once again that for­mer No­var­tis sales rep Steven Cam­burn’s com­plaint lacked suf­fi­cient de­tail to sup­port claims that No­var­tis de­ployed a kick­back scheme to boost Gilenya pre­scrip­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER